Brief: Intra-Cellular Therapies Q3 Net Income USD -26.3 Million
30/10/2024 11:31
Oct 30 (Reuters) - Intra-Cellular Therapies Q3 product revenue USD 175.2 million. * outlook FY product revenue USD 665-685 million
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)